Development of multi-epitope vaccine constructs for non-small cell lung cancer (NSCLC) against USA human leukocyte antigen background: an immunoinformatic approach toward future vaccine designing

References

• Bade BC, Cruz CSD. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24.
   PubMed Web of Science ®Google Scholar
• Shankar A, Dubey A, Saini D, et al. Environmental and occupational determinants of lung cancer. Transl Lung Cancer Res. 2019;8(Suppl 1):S31.
   PubMedGoogle Scholar
• Zhu Q-G, Zhang S-M, Ding -X-X, et al. Driver genes in non-small cell lung cancer: characteristics, detection methods, and targeted therapies. Oncotarget. 2017;8(34):57680.
   PubMedGoogle Scholar
• Spaas M, Lievens Y. Is the combination of immunotherapy and radiotherapy in non-small cell lung cancer a feasible and effective approach? Front Med (Lausanne). 2019;6:244.
   PubMed Web of Science ®Google Scholar
• Kaumaya PT. B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine. Future Oncol. 2020;16(23):1767–1791.
   PubMed Web of Science ®Google Scholar
• Hollingsworth RE, Jansen K. Turning the corner on therapeutic cancer vaccines. Npj Vaccines. 2019;4(1):1–10.
   PubMedGoogle Scholar
• Mahmood MS, Asad-Ullah M, Batool H, et al. Prediction of epitopes of Neisseria Gonorrhoeae against USA human leukocyte antigen background: an immunoinformatic approach towards development of future vaccines for USA population. Mol Cell Probes. 2019;43:40–44.
   PubMed Web of Science ®Google Scholar
• Mahmood MS, Bin-T-Abid D, Irshad S, et al. Analysis of putative epitope candidates of mycobacterium tuberculosis against Pakistani human leukocyte antigen background: an immunoinformatic study for the development of future vaccine. Int J Pept Res Ther. 2021;27(1):597–614.
   PubMedGoogle Scholar
• Batool H, Batool S, Mahmood MS, et al. Prediction of putative epitope‐based vaccine against all corona virus strains for chinese population: approach toward development of vaccine. Microbiol Immunol. 2020;65(4):154-160.
   Web of Science ®Google Scholar
• Nii K, Tokunaga Y, Liu D, et al. Overexpression of G protein-coupled receptor 87 correlates with poorer tumor differentiation and higher tumor proliferation in non-small-cell lung cancer. Mol Clin Oncol. 2014;2(4):539–544.
   PubMedGoogle Scholar
• Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2020;12(8):1–22.
   PubMed Web of Science ®Google Scholar
• Sakashita S, Li D, Nashima N, et al. Overexpression of immunoglobulin (CD79a) binding protein1 (IGBP‐1) in small lung adenocarcinomas and its clinicopathological significance. Pathol Int. 2011;61(3):130–137.
   PubMed Web of Science ®Google Scholar
• Vincent EE, Elder DJ, Phillips L, et al. Overexpression of the TXNDC5 protein in non-small cell lung carcinoma. Anticancer Res. 2011;31(5):1577–1582.
   PubMed Web of Science ®Google Scholar
• Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8(1):1–7.
   PubMedGoogle Scholar
• Dimitrov I, Flower DR, Doytchinova I. AllerTOP-a server for in silico prediction of allergens. BMC Bioinformatics. 2013;14(6):1–9.
   PubMed Web of Science ®Google Scholar
• Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics. 2009;10(1):1–10.
   PubMedGoogle Scholar
• Rosa DS, Tzelepis F, Cunha MG, et al. The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate. Immunol Lett. 2004;92(3):259–268.
   PubMed Web of Science ®Google Scholar
• Shanmugam A, Rajoria S, George AL, et al. Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PloS One. 2012;7(2):e30839.
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun W, Guo J, et al. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Hum Vaccin Immunother. 2015;11(3):795–805.
   PubMed Web of Science ®Google Scholar
• Silacci M, Baenziger-Tobler N, Lembke W, et al. Linker length matters, fynomer-Fc fusion with an optimized linker displaying picomolar IL-17A inhibition potency. J Biol Chem. 2014;289(20):14392–14398.
   PubMed Web of Science ®Google Scholar
• Lichty JJ, Malecki JL, Agnew HD, et al. Comparison of affinity tags for protein purification. Protein Expr Purif. 2005;41(1):98–105.
   PubMed Web of Science ®Google Scholar
• Gasteiger E, Hoogland C, Gattiker A, et al. Protein identification and analysis tools on the ExPASy server. In: The proteomics protocols handbook. Methods Mol Biol. 2005. p. 571–607.
   Google Scholar
• Agostini F, Cirillo D, Livi CM, et al. ccSOL omics: a webserver for large-scale prediction of endogenous and heterologous solubility in E. coli. Bioinformatics. 2014;30(20):2975–2977.
   PubMed Web of Science ®Google Scholar
• Krüger DM, Ahmed A, Gohlke H. NMSim web server: integrated approach for normal mode-based geometric simulations of biologically relevant conformational transitions in proteins. Nucleic Acids Res. 2012;40(W1):W310–W16.
   PubMed Web of Science ®Google Scholar
• Kozakov D, Hall DR, Xia B, et al. The ClusPro web server for protein–protein docking. Nat Protoc. 2017;12(2):255.
   PubMed Web of Science ®Google Scholar
• Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng Des Sel. 1995;8(2):127–134.
   Web of Science ®Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14(1):33–38.
   PubMedGoogle Scholar
• Guadango A. World lung cancer day 2019: facts and Figures. Cure 2019.
   Google Scholar
• Jones GS, Baldwin DR. Recent advances in the management of lung cancer. Clin Med. 2018;18(Suppl 2):s41.
   PubMed Web of Science ®Google Scholar
• Abdelmoneim AH, Mustafa MI, Abdelmageed MI, et al. Immunoinformatics design of multiepitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a target. Immunol Med. 2020;44(1):1–18.
   Google Scholar
• Chauhan V, Rungta T, Goyal K, et al. Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach. Sci Rep. 2019;9(1):1–15.
   PubMed Web of Science ®Google Scholar
• Bezu L, Kepp O, Cerrato G, et al. Trial watch: peptide-based vaccines in anticancer therapy. Oncoimmunology. 2018;7(12):e1511506.
   PubMed Web of Science ®Google Scholar
• Lei Y, Zhao F, Shao J, et al. Application of built-in adjuvants for epitope-based vaccines. PeerJ. 2019;6:e6185.
   PubMed Web of Science ®Google Scholar
• Cuzzubbo S, Mangsbo S, Nagarajan D, et al. Cancer vaccines: adjuvant potency, importance of age, lifestyle, and treatments. Front Immunol. 2021;11:3850.
   Web of Science ®Google Scholar
• Kalaora S, Nagler A, Nejman D, et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature. 2021;592(7852):138–143.
   PubMed Web of Science ®Google Scholar
• Dimou A, Grewe P, Sidney J, et al. HLA class i binding of mutant egfr peptides in NSCLC is associated with improved survival. J Thorac Oncol. 2021;16(1):104–112.
   PubMed Web of Science ®Google Scholar
• La Gruta NL, Gras S, Daley SR, et al. Understanding the drivers of MHC restriction of T cell receptors. Nat Rev Immunol. 2018;18(7):467–478.
   PubMed Web of Science ®Google Scholar
• Okazoe H, Zhang X, Liu D, et al. Expression and role of GPR87 in urothelial carcinoma of the bladder. Int J Mol Sci. 2013;14(6):12367–12379.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou W, Zhong Y, et al. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway. Mol Cancer. 2017;16(1):1–14.
   PubMedGoogle Scholar
• Yan M, Li H, Zhu M, et al. G protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133+ cancer stem-like cells in hepatocellular carcinoma. PloS One. 2013;8(4):e61056.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu D, Hayashida Y, et al. G protein-coupled receptor 87 (GPR87) promotes cell proliferation in human bladder cancer cells. Int J Mol Sci. 2015;16(10):24319–24331.
   PubMed Web of Science ®Google Scholar
• Jiang S, Li D, Liang Z, et al. High expression of IGBP1 correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Biol Markers. 2020;35(1):33–40.
   PubMed Web of Science ®Google Scholar
• Sato T, Shiba‐Ishii A, Kim Y, et al. miR‐3941: a novel microRNA that controls IGBP 1 expression and is associated with malignant progression of lung adenocarcinoma. Cancer Sci. 2017;108(3):536–542.
   PubMed Web of Science ®Google Scholar
• Galván I, Inácio Â, Dañino M, et al. High SLC7A11 expression in normal skin of melanoma patients. Cancer Epidemiol. 2019;62:101582.
   PubMed Web of Science ®Google Scholar
• Ge C, Cao B, Feng D, et al. The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells. Sci Rep. 2017;7(1):1–11.
   PubMedGoogle Scholar
• Zhu J-H, De Mello RA, Yan Q-L, et al. MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165747.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hou Y, Li N, et al. The influence of TXNDC5 gene on gastric cancer cell. J Cancer Res Clin Oncol. 2010;136(10):1497–1505.
   PubMed Web of Science ®Google Scholar
• Zang H, Li Y, Zhang X, et al. Circ_0000517 contributes to Hepatocellular Carcinoma progression by upregulating TXNDC5 via sponging miR-1296-5p. Cancer Manag Res. 2020;12:3457.
   PubMed Web of Science ®Google Scholar
• Wu Z, Zhang L, Li N, et al. An immunohistochemical study of thioredoxin domain-containing 5 expression in gastric adenocarcinoma. Oncol Lett. 2015;9(3):1154–1158.
   Google Scholar
• Tan F, Zhu H, He X, et al. Role of TXNDC5 in tumorigenesis of colorectal cancer cells: in vivo and in vitro evidence. Int J Mol Med. 2018;42(2):935–945.
   PubMed Web of Science ®Google Scholar
• Chang X, Xu B, Wang L, et al. Investigating a pathogenic role for TXNDC5 in tumors. Int J Oncol. 2013;43(6):1871–1884.
   PubMed Web of Science ®Google Scholar
• Dhatchinamoorthy K, Colbert JD, Rock K. Cancer immune evasion through loss of MHC class I antigen presentation. Frontiers in immunology. 2021;12:469.
   Google Scholar
• Zhang F, Zheng Z, Barman AK, et al. Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity. Communications Biology. 2021;4(1):1–14.
   Google Scholar
• Deng C, Xu Y, Fu J, et al. Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma. Cancer science. 2020;111(6):1899.
   Google Scholar
• Crews DW, Dombroski JA, King M. Prophylactic cancer vaccines engineered to elicit specific adaptive immune response. Frontiers in Oncology. 2021;11:994.
   Google Scholar